Toragen Inc
Toragen Inc, based in San Diego, CA, is a clinical-stage oncology company dedicated to developing innovative cancer treatments targeting viral-associated cancers, particularly those induced by Human Papillomavirus (HPV). With a focus on addressing the rising incidence of HPV-related cancers, Toragen is advancing its lead compound, TGNS11, through Phase I clinical trials to improve patient outcomes.
Founded by industry leaders with extensive experience in biotechnology and drug development, Toragen aims to tackle significant health issues such as oropharyngeal squamous cell carcinoma (OPSCC), which is linked to HPV and has high mortality rates. The company is also exploring combination therapies to enhance the efficacy of existing immunotherapies, addressing the critical need for more effective treatment options.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

